937 related articles for article (PubMed ID: 22846738)
1. Genetic testing by cancer site: stomach.
Chun N; Ford JM
Cancer J; 2012; 18(4):355-63. PubMed ID: 22846738
[TBL] [Abstract][Full Text] [Related]
2. [Hereditary gastric cancer. Genetics and clinical management].
Medina-Franco H
Rev Gastroenterol Mex; 2003; 68(1):51-4. PubMed ID: 12940100
[TBL] [Abstract][Full Text] [Related]
3. Hereditary gastric cancer.
Oliveira C; Seruca R; Carneiro F
Best Pract Res Clin Gastroenterol; 2009; 23(2):147-57. PubMed ID: 19414142
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
5. CDH1 associated gastric cancer: a report of a family and review of the literature.
Moran CJ; Joyce M; McAnena OJ
Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
8. Familial gastric cancer: overview and guidelines for management.
Caldas C; Carneiro F; Lynch HT; Yokota J; Wiesner GL; Powell SM; Lewis FR; Huntsman DG; Pharoah PD; Jankowski JA; MacLeod P; Vogelsang H; Keller G; Park KG; Richards FM; Maher ER; Gayther SA; Oliveira C; Grehan N; Wight D; Seruca R; Roviello F; Ponder BA; Jackson CE
J Med Genet; 1999 Dec; 36(12):873-80. PubMed ID: 10593993
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin germline mutation carriers: clinical management and genetic implications.
Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
[TBL] [Abstract][Full Text] [Related]
10. [Familial gastric cancer: diagnosis, treatment and periodic surveillance].
Kluijt I; Sijmons RH; Hoogerbrugge N; Vasen HF; Cats A
Ned Tijdschr Geneeskd; 2011; 155():A2731. PubMed ID: 21329544
[TBL] [Abstract][Full Text] [Related]
11. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
Cisco RM; Norton JA
Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
[TBL] [Abstract][Full Text] [Related]
12. Familial and hereditary gastric cancer, an overview.
Carneiro F
Best Pract Res Clin Gastroenterol; 2022; 58-59():101800. PubMed ID: 35988963
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
[TBL] [Abstract][Full Text] [Related]
14. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred.
Oliveira C; Bordin MC; Grehan N; Huntsman D; Suriano G; Machado JC; Kiviluoto T; Aaltonen L; Jackson CE; Seruca R; Caldas C
Hum Mutat; 2002 May; 19(5):510-7. PubMed ID: 11968083
[TBL] [Abstract][Full Text] [Related]
15. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
16. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
17. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
[TBL] [Abstract][Full Text] [Related]
18. Genetic screening for hereditary diffuse gastric cancer.
Oliveira C; Seruca R; Caldas C
Expert Rev Mol Diagn; 2003 Mar; 3(2):201-15. PubMed ID: 12647996
[TBL] [Abstract][Full Text] [Related]
19. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer.
Carneiro F; Oliveira C; Suriano G; Seruca R
J Clin Pathol; 2008 Jan; 61(1):25-30. PubMed ID: 17513507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]